Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer

Journal:

Nature Communications

Published:

2026-04-03

DOI:

10.1038/s41467-026-71468-y

Affiliations:

5

Authors:

18

Go to article

Institutions	Authors	Share
University of Wisconsin-Madison (UW-Madison), United States of America (USA)	11.000000 11.000000	0.61
Medical College of Wisconsin (MCW), United States of America (USA)	3.000000	0.17
Boston Children's Hospital (BCH), United States of America (USA)	2.000000	0.11
Versiti Blood Research Institute, United States of America (USA)	2.000000	0.11

Interested in Oncology and Carcinogenesis?